Experimental eye injection aims to restore sight in rare blindness conditions
NCT ID NCT05282953
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 32 times
Summary
This study tested an experimental drug called KIO-301, given as an injection into the eye, in 32 adults with retinitis pigmentosa or choroideremia—two inherited diseases that cause progressive vision loss. The main goal was to check safety and see if the drug could improve vision. Researchers looked for side effects and measured changes in the retina and overall eye health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Harley Eye Clinic
North Adelaide, South Australia, 5006, Australia
-
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
-
Save Sight Institute
Sydney, New South Wales, 2001, Australia
Conditions
Explore the condition pages connected to this study.